Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin

MeSH terms

• Adult
• Aged
• Anemia / blood*
• Anemia / drug therapy
• Blood Viscosity / drug effects*
• Erythrocyte Aggregation / drug effects*
• Erythropoietin / adverse effects*
• Erythropoietin / therapeutic use
• Female
• Fibrinogen / analysis*
• Hematocrit
• Humans
• Hypertension / etiology
• Male
• Middle Aged
• Recombinant Proteins / adverse effects
• Recombinant Proteins / therapeutic use
• Renal Dialysis* / adverse effects
• Rheology
• Thrombosis / etiology